These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Glycogen synthase kinase-3beta, beta-catenin, and tau in postmortem bipolar brain. Lesort M; Greendorfer A; Stockmeier C; Johnson GV; Jope RS J Neural Transm (Vienna); 1999; 106(11-12):1217-22. PubMed ID: 10651115 [TBL] [Abstract][Full Text] [Related]
9. Lack of effect of acute, subchronic, or chronic stress on glycogen synthase kinase-3beta protein levels in rat frontal cortex. Kozlovsky N; Belmaker RH; Agam G Prog Neuropsychopharmacol Biol Psychiatry; 2002 Dec; 26(7-8):1309-12. PubMed ID: 12502018 [TBL] [Abstract][Full Text] [Related]
10. Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia. Amar S; Shaltiel G; Mann L; Shamir A; Dean B; Scarr E; Bersudsky Y; Belmaker RH; Agam G Int J Neuropsychopharmacol; 2008 Mar; 11(2):197-205. PubMed ID: 17681085 [TBL] [Abstract][Full Text] [Related]
11. Association of GSK-3β genetic variation with GSK-3β expression, prefrontal cortical thickness, prefrontal physiology, and schizophrenia. Blasi G; Napolitano F; Ursini G; Di Giorgio A; Caforio G; Taurisano P; Fazio L; Gelao B; Attrotto MT; Colagiorgio L; Todarello G; Piva F; Papazacharias A; Masellis R; Mancini M; Porcelli A; Romano R; Rampino A; Quarto T; Giulietti M; Lipska BK; Kleinman JE; Popolizio T; Weinberger DR; Usiello A; Bertolino A Am J Psychiatry; 2013 Aug; 170(8):868-76. PubMed ID: 23598903 [TBL] [Abstract][Full Text] [Related]
12. Dysfunction of protein kinase FA/GSK-3 alpha in lymphocytes of patients with schizophrenic disorder. Yang SD; Yu JS; Lee TT; Yang CC; Ni MH; Yang YY J Cell Biochem; 1995 Sep; 59(1):108-16. PubMed ID: 8530529 [TBL] [Abstract][Full Text] [Related]
13. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease. Leroy K; Boutajangout A; Authelet M; Woodgett JR; Anderton BH; Brion JP Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173 [TBL] [Abstract][Full Text] [Related]
15. Glycogen synthase kinase (GSK)-3beta levels and activity in a neurodevelopmental rat model of schizophrenia. Nadri C; Lipska BK; Kozlovsky N; Weinberger DR; Belmaker RH; Agam G Brain Res Dev Brain Res; 2003 Mar; 141(1-2):33-7. PubMed ID: 12644246 [TBL] [Abstract][Full Text] [Related]
16. GSK-3 and the neurodevelopmental hypothesis of schizophrenia. Kozlovsky N; Belmaker RH; Agam G Eur Neuropsychopharmacol; 2002 Feb; 12(1):13-25. PubMed ID: 11788236 [TBL] [Abstract][Full Text] [Related]
17. Expression of Oct-6, a POU III domain transcription factor, in schizophrenia. Ilia M; Beasley C; Meijer D; Kerwin R; Cotter D; Everall I; Price J Am J Psychiatry; 2002 Jul; 159(7):1174-82. PubMed ID: 12091196 [TBL] [Abstract][Full Text] [Related]
18. Cytosolic prostaglandin E2 synthase (cPGES) expression is decreased in discrete cortical regions in psychiatric disease. Maida ME; Hurley SD; Daeschner JA; Moore AH; O'Banion MK Brain Res; 2006 Aug; 1103(1):164-72. PubMed ID: 16806120 [TBL] [Abstract][Full Text] [Related]
19. Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder. Szczepankiewicz A; Skibinska M; Hauser J; Slopien A; Leszczynska-Rodziewicz A; Kapelski P; Dmitrzak-Weglarz M; Czerski PM; Rybakowski JK Neuropsychobiology; 2006; 53(1):51-6. PubMed ID: 16397405 [TBL] [Abstract][Full Text] [Related]
20. Dual effects of PKNalpha and protein kinase C on phosphorylation of tau protein by glycogen synthase kinase-3beta. Isagawa T; Mukai H; Oishi K; Taniguchi T; Hasegawa H; Kawamata T; Tanaka C; Ono Y Biochem Biophys Res Commun; 2000 Jun; 273(1):209-12. PubMed ID: 10873588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]